Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009;5(1):97-100.
Epub 2009 Apr 8.

Effect of losartan on Doppler sonography indices in kidney transplant patients: a randomized clinical trial

Affiliations
Randomized Controlled Trial

Effect of losartan on Doppler sonography indices in kidney transplant patients: a randomized clinical trial

Nader Nouri-Majalan et al. Vasc Health Risk Manag. 2009.

Abstract

Background: Color Doppler sonography indices, such as resistive index (RI) and pulsatility index (PI), can predict arteriosclerosis of internal renal vessels after kidney transplantation. Angiotensin II receptor antagonists, however, may have antiatherogenic effects. We therefore assessed the effects of losartan on RIs of renal allografts.

Methods: We compared duplex sonographic measurements in renal allograft recipients (30 males, 20 females) from living donors randomized to a losartan (25 mg twice daily) or a control group.

Results: The patients in the two groups had similar baseline characteristics, and 49 (24 in the losartan and 25 in the control group) completed 12 months of follow-up. After 12 months, the losartan and control groups did not differ significantly in mean RI (0.71 +/- 0.06 vs 0.69 +/- 0.07, P = 0.4) or PI (1.3 +/- 0.25 vs 1.29 +/- 0.28, P = 0.8) of the intrarenal artery and mean RI (0.74 +/- 0.07 vs 0.72 +/- 0.07, P = 0.3) and PI (1.5 +/- 0.3 vs 1.4 +/- 0.34, P = 0.3) of the main artery.

Conclusions: Losartan had no effect on Doppler sonography indices. Longer follow-up, however, may be needed to confirm this finding.

Keywords: Doppler ultrasonography; kidney transplantation; losartan.

PubMed Disclaimer

References

    1. Campistol JM, Inigo P, Larios S, Bescos M, Oppenheimer F. Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy. Nephrol Dial Transplant. 2001;16(Suppl 1):114–116. - PubMed
    1. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int. 1993;44:411–422. - PubMed
    1. Matas AJ, Burke JF, Jr, DeVault GA, Jr, Monaco A, Pirsch JD. Chronic rejection. J Am Soc Nephrol. 1994;4(8 Suppl):S23–S29. - PubMed
    1. Shihab FS, Tanner AM, Shao Y, Weffer MI. Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int. 1996;50:1904–1913. - PubMed
    1. Iino K, Ito H. [Use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in patients with acute coronary syndrome] Nippon Rinsho. 2006;64:734–741. - PubMed

Publication types

Substances